This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $493,634 to the University of Washington. The funding aims to conduct qualitative and quantitative research to examine the preferences and acceptability of pre-exposure prophylaxis (PrEP) among transgender women in the Philippines. Specifically, the grant will:
-
Conduct in-depth interviews with 30 transgender women and 15 key informants to explore preferred attributes and features of PrEP programs.
-
Use a full-profile choice-based conjoint study design with 300 transgender women in the Philippines to quantify their preferences for optimal PrEP program attributes and identify socio-ecological factors influencing PrEP uptake.
The findings will inform the development of a future behavioral economic-based intervention to support PrEP engagement among transgender women and reduce HIV incidence in the Philippines.
Generated 1/28/25, 9:08 AM